Kreon 25000 (Pancreatin)

Pancreatin provides a mixture of digestive enzymes—lipases, proteases and amylases—that become active in the duodenum after oral ingestion. The lipases hydrolyze triglycerides into fatty acids and monoglycerides, proteases split proteins into peptides and amino acids, and amylases break down starches into simple sugars. This enzymatic activity compensates for the deficient endogenous pancreatic secretion, facilitating nutrient absorption.

The dose of Kreon 25000 is individualized by the prescribing healthcare professional based on the severity of enzyme deficiency, the patient’s body weight, and the fat content of each meal. Typically, the product is taken with every main meal and snack, and the prescriber may adjust the number of capsules to achieve optimal digestive control. Patients should follow the exact dosing instructions provided by their clinician.

Safety data for pancreatin products in pregnancy and lactation are limited, and the medication should only be used if the potential benefit outweighs any possible risk to the fetus or infant. Healthcare providers usually assess the need for enzyme replacement on a case‑by‑case basis. Breastfeeding mothers should discuss use with their physician, as small amounts of the enzymes may be secreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Kreon 25000. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details—including any temperature‑controlled handling if needed—and assists with import documentation.

Kreon 25000 is a high‑potency pancreatin formulation that delivers a standardized amount of lipase activity per capsule, which can be advantageous for patients requiring strong enzyme support. Compared with some lower‑strength preparations, Kreon may achieve the desired digestive effect with fewer capsules per meal. However, choice of product depends on individual patient needs, physician preference, and insurance coverage.

Kreon 25000 should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the capsules in the original blister pack or bottle, protect them from moisture, heat and direct sunlight. Do not refrigerate or freeze the product, as extreme temperatures may degrade enzyme activity and affect efficacy.

Kreon 25000 is taken orally, usually with each main meal and snack that contains fat, protein or carbohydrate. The capsules should be swallowed whole with a glass of water; they should not be crushed, chewed or opened unless specifically instructed by a healthcare professional. Proper timing with food maximizes enzyme activation in the gastrointestinal tract.

Although rare, serious adverse events can include pancreatitis, severe allergic reactions such as anaphylaxis, and significant abdominal pain that may signal a gastrointestinal complication. Patients experiencing these symptoms should seek immediate medical attention. Prompt reporting of any unexpected reactions helps clinicians assess the risk‑benefit balance of continued therapy.

Kreon 25000 is contraindicated in individuals with known hypersensitivity to pancreatin or any of the product’s excipients. Patients with active gastrointestinal bleeding, untreated peptic ulcer disease, or severe inflammatory bowel disease should avoid use until the underlying condition is managed. As always, a qualified healthcare professional must evaluate suitability before initiating therapy.